InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
5,648.40
(
1.01%
)
US TECH 100
19,050.40
(
1.19%
)
Dow Jones
41,563.08
(
0.55%
)
Brent Oil
76.78
(
0.60%
)
Bitcoin
58,125.01
(
1.39%
)
Post# of 30990
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next

seek the light

Send PM Follow Ignore
Followers 53
Posts 7442
Boards Moderated 0
Alias Born 08/24/2010

seek the light

Re: leifsmith post# 21587

Monday, 12/29/2014 9:29:02 AM

Monday, December 29, 2014 9:29:02 AM

Post# of 30990
The new formulations are "slow release" and the tissue tests are checking for bioavailability. The CTA is a dose escalation study.

Checking bioavailability. In pharmacology, bioavailability (BA) is a subcategory of absorption and is the fraction of an administered dose of unchanged drug that reaches the systemic circulation, one of the principal pharmacokinetic properties of drugs. By definition, when a medication is administered intravenously, its bioavailability is 100%.
Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next
Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up